Ledger.Open graph →
SEC Form D · filed November 18, 2015

Therabron Therapeutics, Inc

Offering
$6.7M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffrey M. Zell · ROCKVILLE, MDDirectorVinzenz M. Ploerer · ROCKVILLE, MDDirectorAprile L. Pilon-Clayton · ROCKVILLE, MDExec · DirectorChristine M. Copple · ROCKVILLE, MDDirectorBlanche M. Johnson · ROCKVILLE, MDExec · DirectorThomas M. Miller · El Cajon, CAExecJeffrey M. Zell · ROCKVILLE, MDDirectorVinzenz M. Ploerer · ROCKVILLE, MDDirectorThomas M. Miller · ROCKVILLE, MDExecAprile L. Pilon-Clayton · ROCKVILLE, MDExec · DirectorChristine M. Copple · ROCKVILLE, MDDirectorBlanche M. Johnson · ROCKVILLE, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗